Article Details
Retrieved on: 2021-06-17 17:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Durvalumab is a checkpoint inhibitor immunotherapy engineered to unleash immune system T cells against tumors by inhibiting a protein on the ...
Article found on: www.news-medical.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here